Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Taniyama

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Anticancer Research|December 31, 1997
Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinomaH Sasano, A R Frost, R Saitoh, et al.
Journal of the American College of Cardiology|March 18, 1999
Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarctionH Ito, Y Taniyama, K Iwakura, et al.
Gene Therapy|March 1, 2000
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, etsM Aoki, R Morishita, Y Taniyama, et al.
Gene Therapy|April 21, 2001
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial diseaseY Taniyama, R Morishita, M Aoki, et al.
Journal of Hypertension|November 1, 2000
Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cellsH Nakagami, R Morishita, K Yamamoto, et al.
Circulation|November 7, 2001
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetesY Taniyama, R Morishita, K Hiraoka, et al.
Circulation|July 13, 2000
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamstersY Taniyama, R Morishita, H Nakagami, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 21, 2001
A family with von Hippel-Lindau disease revealed by pheochromocytomaN Tomita, A Moriguchi, K Yamasaki, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2000
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21S Hayashi, R Morishita, H Matsushita, et al.
Circulation|March 29, 2000
Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cellsH Matsushita, R Morishita, M Aoki, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Anticancer Research|December 31, 1997
Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinomaH Sasano, A R Frost, R Saitoh, et al.
Journal of the American College of Cardiology|March 18, 1999
Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarctionH Ito, Y Taniyama, K Iwakura, et al.
Gene Therapy|March 1, 2000
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, etsM Aoki, R Morishita, Y Taniyama, et al.
Gene Therapy|April 21, 2001
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial diseaseY Taniyama, R Morishita, M Aoki, et al.
Journal of Hypertension|November 1, 2000
Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cellsH Nakagami, R Morishita, K Yamamoto, et al.
Circulation|November 7, 2001
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetesY Taniyama, R Morishita, K Hiraoka, et al.
Circulation|July 13, 2000
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamstersY Taniyama, R Morishita, H Nakagami, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 21, 2001
A family with von Hippel-Lindau disease revealed by pheochromocytomaN Tomita, A Moriguchi, K Yamasaki, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2000
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21S Hayashi, R Morishita, H Matsushita, et al.
Circulation|March 29, 2000
Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cellsH Matsushita, R Morishita, M Aoki, et al.
Pageof 8